Tjoapack Expands Bottle Packaging at Netherlands Facility

Why It Matters

The new line strengthens Tjoapack’s ability to meet growing demand for flexible, compliant oral solid‑dosage packaging, giving it a competitive edge in Europe and globally. It also signals broader strategic expansion that could attract pharma clients seeking integrated, high‑speed packaging solutions.

Key Takeaways

• New Cremer Uhlmann IBC 50 line handles 50 bottles/minute.
• Line supports any bottle shape, cartons, leaflets, shrink wrap.
• Enhances Tjoapack’s flexible, GMP‑compliant packaging capabilities.
• Complements US expansion, boosting global service footprint.
• Tjoapack to demo solutions at Pharmapack Europe 2026.

Pulse Analysis

The pharmaceutical packaging sector is experiencing a surge in demand for versatile, high‑throughput solutions as oral solid‑dosage products dominate global drug pipelines. Manufacturers are seeking partners that can quickly adapt to varied bottle formats, regulatory requirements, and supply‑chain constraints. Tjoapack’s decision to install a Cremer Uhlmann IBC 50 line in the Netherlands directly addresses these market pressures, positioning the company as a go‑to provider for flexible, GMP‑compliant packaging across Europe.

The IBC 50 system brings automation capable of processing up to 50 bottles per minute, regardless of shape, and seamlessly integrates secondary operations such as carton loading, leaflet insertion, and shrink‑wrap sealing. This level of flexibility reduces change‑over times, minimizes line downtime, and ensures consistent product integrity—critical factors for pharma firms facing tight launch schedules and stringent quality standards. By consolidating multiple packaging configurations onto a single line, Tjoapack can offer cost‑effective, scalable solutions that align with clients’ evolving product portfolios.

Beyond the technical upgrade, the expansion reflects Tjoapack’s broader strategic push, complementing its recent U.S. facility growth and reinforcing a transatlantic service network. Showcasing the new capabilities at Pharmapack Europe 2026 will allow the company to demonstrate end‑to‑end packaging expertise to a global audience, potentially accelerating client acquisition and deepening existing partnerships. This integrated approach underscores Tjoapack’s commitment to operational excellence and positions it to capture a larger share of the expanding pharmaceutical bottle‑packaging market.